580 related articles for article (PubMed ID: 23970749)
1. Liver function test abnormalities in Nigerian patients with human immunodeficiency virus and hepatitis B virus co-infection.
Iroezindu MO; Agbaji OO; Daniyam CA; Isiguzo GC; Isichei C; Akanbi MO
Int J STD AIDS; 2013 Jun; 24(6):461-7. PubMed ID: 23970749
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of hepatitis B e antigen among human immunodeficiency virus and hepatitis B virus co-infected patients in Jos, Nigeria.
Iroezindu MO; Daniyam CA; Agbaji OO; Isa ES; Okeke EN; Imade GE
J Infect Dev Ctries; 2013 Dec; 7(12):951-9. PubMed ID: 24334942
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ
Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
[TBL] [Abstract][Full Text] [Related]
4. Human immuno-deficiency virus and hepatitis B virus coinfection in pregnancy at the University College Hospital, Ibadan.
Adesina O; Oladokun A; Akinyemi O; Adedokun B; Awolude O; Odaibo G; Olaleye D; Adewole I
Afr J Med Med Sci; 2010 Dec; 39(4):305-10. PubMed ID: 21735996
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus genotype G: prevalence and impact in patients co-infected with human immunodeficiency virus.
Dao DY; Balko J; Attar N; Neak E; Yuan HJ; Lee WM; Jain MK
J Med Virol; 2011 Sep; 83(9):1551-8. PubMed ID: 21739445
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
[TBL] [Abstract][Full Text] [Related]
7. Baseline characteristics of HIV & hepatitis B virus (HIV/HBV) co-infected patients from Kolkata, India.
Sarkar J; Saha D; Bandyopadhyay B; Saha B; Kedia D; Guha Mazumder DN; Chakravarty R; Guha SK
Indian J Med Res; 2016 May; 143(5):636-42. PubMed ID: 27488008
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.
Sagoe KW; Agyei AA; Ziga F; Lartey M; Adiku TK; Seshi M; Arens MQ; Mingle JA
J Med Virol; 2012 Jan; 84(1):6-10. PubMed ID: 22095533
[TBL] [Abstract][Full Text] [Related]
9. Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study.
Lunel-Fabiani F; Mansour W; Amar AO; Aye M; Le Gal F; Malick FZ; Baïdy L; Brichler S; Veillon P; Ducancelle A; Gordien E; Rosenheim M
J Infect; 2013 Nov; 67(5):448-57. PubMed ID: 23796871
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians.
Grant J; Agbaji O; Kramvis A; Yousif M; Auwal M; Penugonda S; Ugoagwu P; Murphy R; Hawkins C
Trop Med Int Health; 2017 Jun; 22(6):744-754. PubMed ID: 28376292
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.
Otegbayo JA; Taiwo BO; Akingbola TS; Odaibo GN; Adedapo KS; Penugonda S; Adewole IF; Olaleye DO; Murphy R; Kanki P
Ann Hepatol; 2008; 7(2):152-6. PubMed ID: 18626434
[TBL] [Abstract][Full Text] [Related]
12. Development of chronic hepatitis B virus infection in hepatitis B surface antigen negative HIV/HBV co-infected adults: a rare opportunistic illness.
Landrum ML; Roediger MP; Fieberg AM; Weintrob AC; Okulicz JF; Crum-Cianflone NF; Ganesan A; Lalani T; Macalino GE; Chun HM
J Med Virol; 2011 Sep; 83(9):1537-43. PubMed ID: 21739443
[TBL] [Abstract][Full Text] [Related]
13. Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared.
Wandeler G; Mulenga L; Vinikoor MJ; Kovari H; Battegay M; Calmy A; Cavassini M; Bernasconi E; Schmid P; Bolton-Moore C; Sinkala E; Chi BH; Egger M; Rauch A;
Int J Infect Dis; 2016 Oct; 51():97-102. PubMed ID: 27596685
[TBL] [Abstract][Full Text] [Related]
14. [A cross-sectional survey of occult hepatitis B virus infection in HIV-infected patients].
Ma JX; Lu HZ; Wang JR; Zhang RF; Zheng YF; Liu L; Qi TK; Shen YZ
Zhonghua Nei Ke Za Zhi; 2008 Jul; 47(7):574-7. PubMed ID: 19035170
[TBL] [Abstract][Full Text] [Related]
15. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
Gupta S; Singh S
BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948
[TBL] [Abstract][Full Text] [Related]
16. Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.
Sheng WH; Hung CC; Chang SY; Liu CJ; Chen MY; Hsieh SM; Kao JH; Chen PJ; Chang SC
Clin Infect Dis; 2012 Feb; 54(4):548-55. PubMed ID: 22156858
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of occult hepatitis B in HIV infected patients].
Altınbaş A; Ergünay K; Calık Başaran N; Alp A; Turgut D; Hasçelik G; Uzun Ö; Unal S
Mikrobiyol Bul; 2011 Apr; 45(2):353-8. PubMed ID: 21644079
[TBL] [Abstract][Full Text] [Related]
18. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.
Azadmanesh K; Mohraz M; Aghakhani A; Edalat R; Jam S; Eslamifar A; Banifazl M; Moradmand-Badie B; Ramezani A
Intervirology; 2008; 51(4):270-4. PubMed ID: 18841029
[TBL] [Abstract][Full Text] [Related]
19. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
[TBL] [Abstract][Full Text] [Related]
20. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]